http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103316346-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-515 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate | 2013-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103316346-B |
| titleOfInvention | Treat the pharmaceutical composition of epilepsy |
| abstract | The present invention relates to a kind of compositions for treating epilepsy, belong to pharmaceutical technology field.The present invention provides a kind of compound medicament compositions for treating epilepsy, which is characterized in that containing chlocibutamine and central nervous system depressant, wherein, the one kind of central nervous system depressant in barbiturates or Benzodiazepines.The present invention provides a kind of compositions, to improve the compliance of patient, achieve the purpose that control epileptic attack, while reduce the side effect of central nervous system depressant clinical application.A kind of safe and effective clinical application is provided for epileptic. |
| priorityDate | 2013-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.